One-year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus-eluting scaffold in patients with single de novo coronary artery lesions

Author:

Wang Xiao-Zeng1,Zhang Yao-Jun2,Fu Guo-Sheng3,Jing Quan-Min1,Xu Bo4,Han Ya-Ling1

Affiliation:

1. The General Hospital of Shenyang Military; Shenyang China

2. Xuzhou Third People's Hospital, Jiangsu University; Zhenjiang China

3. Sir Run Shaw Hospital, School of Medicine; Zhejiang University; Hangzhou China

4. Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences; Beijing China

Funder

Lepu Medical

National Key Technology R&D Program in the 12th Five-Year Plan of China, Beijing, China

Key Project of the National 12th Five-Year Research Program of China, Beijing, China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference15 articles.

1. Bioresorbable scaffolds: Current evidence and ongoing clinical trials;Bourantas;Curr Cardiol Rep,2012

2. Bioresorbable scaffolds for coronary artery disease: Current status and future prospective;Zhang;Chin Med J,2014

3. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia;Kay;Circulation,2001

4. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy;McFadden;Lancet,2004

5. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation;Hofma;Eur Heart J,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3